Additional candidates are reported to be involved in cancer prognosis and progression, including TSPAN11 (Liu et al., 2021a), NKX6-1 (Su et al., 2021), and SLC16A1 (Zhang et al., 2021). Here, NKX6-1 is linked to cancer.